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Abstract 
Background: To compare buccal midazolam with 
rectal diazepam in status epilepticus in terms of 
recurrence of seizures and risk for treatment failure 
Methods:  In this randomized controlled study a 
total of 410 children with  status epilepticus 
irrespective of cause were included. Patients were 
randomly divided into two groups. Patients in group 
A (n=205) were treated with buccal midazolam 0.3 
mg/kg/dose and patients in group B (n=205) were 
treated with rectal diazepam 0.3 mg/kg/dose. Both 
groups were observed for duration of controlling of 
seizures within 10 minutes to see the risk for 
treatment failure and to check for recurrence of 
seizure within one hour after initial control of 
seizure. 
Results:  The average age of the patients was 
4.66±2.95 years. Mean age was not significant 
between groups while mean duration of control of 
seizure was significant between groups. Recurrence 
was significantly high in group B as compared to 
group A.  Group A was more effective than group B 
because the recurrence rate was low and treatment 
was significantly effective (p=0.002).   
Conclusion: - Buccal midazolam offers a 
promising alternative to rectal diazepam for the 
treatment of seizures in children.  
Key Words: Seizures, Buccal midazolam, Rectal 
diazepam, Status  Epilepticus 
 
Introduction 
Transient occurrence of signs and symptoms resulting 
from abnormal neuronal activity in the brain is 
seizure. Status epilepticus (SE) is defined as a 
persistent epileptic seizure lasting 30 minutes or 
longer that is either continuous or intermittent without 
recovery of consciousness between seizures.1  Seizures 
continuing beyond 5 minutes have the potential of 
progressing into full blown SE.2 The estimated 
incidence of childhood  SE is between 17 to 23 
episodes per 100,000 per year.3  The highest incidence 
is in the first year of life.  
Among types of SE, convulsive SE is the most fatal 
type. Non convulsive SE is less severe but early 
intervention may prevent bad outcome and secondary 
complications.4  The outcome of SE depends upon the 
underlying cause, the duration of the seizure and the 
age of the child. The reported mortality rate of SE in 
children varies between 3 and 9 percent.5,6 Recurrent 
SE occurred in 16 to 17 percent in the first year of 
follow-up. Recurrent SE occurred primarily in 
neurologically abnormal children.7    Refractory SE, 
defined as persistent seizure activity despite 
appropriate therapy, is associated with high mortality 
and morbidity.8  
Causes of SE include central nervous system 
infections, acute hypoxic ischemic insult, metabolic 
causes (e.g hypoglycemia, inborn errors of 
metabolism), electrolyte imbalance, traumatic brain 
injury, drugs, intoxication, poisoning and 
cerebrovascular event.9 Febrile SE is the most common 
etiology.10  
Duration of seizure activity impacts morbidity and 
mortality, effective methods for seizure control should 
be instituted as soon as possible preferably at home. 
The value of early treatment in seizures in reducing 
seizure-related morbidity has been established.11 It has 
also been shown that prompt treatment of episodes of 
seizure at home results in need of fewer drugs at 
hospital and quicker control of the seizure.12 Stoppage 
of seizure was 80 % when first-line antiepileptic drug 
was started less than 2 hours and was 40 % when 
treatment was started after 2 hours.13 Traditionally, 
benzodiazepines or other anticonvulsants have been 
given intravenously. The main problem in the 
management of the child actively showing seizure is 
the delay in reaching hospital and gaining an 
intravenous access. Rectal diazepam offers an 
alternative method of delivery. The long term 
prognosis for seizure cessation tends to be better in 
children than adults, particularly those who are 
neurologically intact.14  
Journal of Rawalpindi Medical College (JRMC); 2015;19(3):197-199 
 
 198 
Patients and Methods  
It is a randomized controlled study which was 
conducted in Paediatric Department of Holy Family 
Hospital Rawalpindi for one year from January 2014 to 
December 2014. Patients included were of age 3 
months to 12 years of both sexes with documented SE. 
The patients having documented evidence of receiving 
intravenous antiepileptic drug before presentation 
were not included in the study. A total of 410 patients 
with SE irrespective of cause were included in this 
study. They were randomly divided into two groups, 
A and B. Group A (n=205)was given buccal 
midazolam 0.3 mg /kg/dose. Group B (n=205) was 
given rectal diazepam 0.3 mg/kg/dose. Both groups 
were observed for duration of controlling of seizures 
within 10 minutes to see the risk for treatment failure 
and to check for occurrence of seizure within 1 hour 
after initial control of seizure.    
Results 
Majority of the children were in age group 1 to 6 years 
(Table1). The average age of the patients was 4.66 ± 
2.95 years. Mean age was not significant between 
groups while mean duration of control of seizure was 
significant between groups (Table 2). Out of 410 
patients, 52% (213/410) were male. The recurrence of 
seizures in subsequent hour after initial control of 
seizure was 20% (41/205) with rectal diazepam and 
9.3% (19/205) with buccal midazolam. Recurrence was 
significantly high in group B as compared to group A 
(Table 3). According to operational definition of 
efficacy, group A was more effective than group B 
because its recurrence rate was low and treatment was 
significantly effective (p=0.002) (Table 4).  
Table 1:  Paediatric Status Epilepticus- Age 
distribution 
Age (years) Group A (No(%)) Group B(No(%)) 
< 1  21 (10.24) 44 (21.46) 
1 -6 131(63.90) 106(51.71) 
7-12 53 (25.85) 55 (26.83) 
Table 2:Comparison of characteristics 











7.54±6.29 9.96±8.71 0.001 
Table 3: Recurrence of Seizures 




Yes 19(9.3) 41(20.0) 
No 186(90.7) 164 (8.0) 
 According to gender stratification, for male cases, 
efficacy was high in group A than B but statistically 
not significant (p=0.125) (Table 5),while in female 
cases efficacy was significantly high in group A than 
group B (p=0.005)(Table 6). 
 









Yes 186(90.7%) 164(80%) 350(85.4%) 
0.002 
No 19(9.3%) 41(20%) 60(14.6%) 
Chi-Square = 9.45  
Table 5:Comparison of efficacy between groups 









Yes 98(89.9%) 86(82.7%) 184(86.4%) 
0.125 
No 11(10.1%) 18(17.3%) 29(13.6%) 
Chi-Square = 2.35  
 
Table 6:Comparison of efficacy between groups 









Yes 88(91.7%) 78(77.2%) 166(84.3%) 
0.005 
No 8(8.3%) 23(22.8%) 31(15.7%) 
Chi-Square = 7.73  
Discussion 
Seizures lie among prevalent diseases of childhood 
and occur in 10% of children.15 In the emergency 
setting, the intravenous route is considered as the most 
suitable method, delivering adequate quantities of 
benzodiazepines in a short time. When intravenous 
administration is not available, other forms of 
benzodiazepine administration such as rectal 
diazepam or buccal midazolam may offer an 
alternative way of drug administration.16Midazolam, 
an inexpensive benzodiazepine with anticonvulsive 
activity, can be administered via multiple routes, 
including topical application in the buccal cavity.17 
Buccal midazolam has been found to be as effective 
and safe as rectal diazepam in control of seizures in 
developed countries.18  Potential advantages of buccal 
midazolam over rectal diazepam include improved 
efficacy, at least in developed countries, ease of 
administration, and safety.19 
In the present study the average age of the patients 
was 4.66 ± 2.95 years. Out of 410 patients, 52% 
(213/410) were male and 48% (197/410) were female. 
In a study conducted by Tonekaboni et al, fifty-one 
(55.4%) out of 92 patients were male and forty one  
(44.6%) were female.20In our study, the recurrence of 
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seizures in subsequent hour after initial control of 
seizure was 20% (41/205) with rectal diazepam and 
9.3% (19/205) with buccal midazolam. Similar result 
was also observed in a study conducted by Mpimbaza 
A et al, where the recurrence of seizures in subsequent 
hour after initial control of seizure was 17.5% with 
rectal diazepam and 8% with buccal midazolam.21 
According to operational definition of efficacy, Group 
A was more effective than group B because the 
recurrence rate was low and treatment was 
significantly effective (p=0.002). In the study 
conducted by Thomas Marshal, buccal midazolam was 
found effective in seizure attacks.22 In a study 
conducted in China, comparison of midazolam was 
done with diazepam that showed different results and 
there was no significant difference in between two 
drugs in controlling seizures.23 In a study conducted in 
India comparison of buccal midazolam was done with 
diazepam via another route that proved buccal 
midazolam can be used as an alternative to rectal or 
intravenous diazepam.24 In one study conducted in 
Iran, efficacy of buccal midazolam was studied that 
showed it is more effective than rectal diazepam and 
easy to use as a buccal route.25 
 
Conclusions 
1.Buccal midazolam offers a promising alternative to 
rectal diazepam for the treatment of seizures in 
children. Midazolam offers benefits over diazepam in 
ease of use, improved efficacy over 1 hour, and a more 
prolonged anticonvulsive effect.  
2.Buccal midazolam may be a more effective bridge to 
long-acting agents in children who need prolonged 
anticonvulsant therapy.  
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